CoChat

Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions

Open access
The Cava Trem Study Group, León, Cristóbal, Ruiz-Santana, Sergio, Saavedra, Pedro, Castro, Carmen, Loza, Ana, Zakariya, Ismail, Úbeda, Alejandro, Parra, Manuel, Macías, Desirée, Tomás, José Ignacio, Rezusta, Antonio, Rodríguez, Alejandro, Gómez, Frederic, Martín-Mazuelos, Estrella · 2016 · Critical Care

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

BACKGROUND: To assess the performance of Candida albicans germ tube antibody (CAGTA), (1 → 3)-ß-D-glucan (BDG), mannan antigen (mannan-Ag), anti-mannan antibodies (mannan-Ab), and Candida DNA for diagnosing invasive candidiasis (IC) in ICU patients with severe abdominal conditions (SAC). METHODS: A prospective study of 233 non-neutropenic patients with SAC on ICU admission and expected stay ≥ 7 days. CAGTA (cutoff positivity ≥ 1/160), BDG (≥80, 100 and 200 pg/mL), mannan-Ag (≥60 pg/mL), mannan-Ab (≥10 UA/mL) were measured twice a week, and Candida DNA only in patients treated with systemic antifungals. IC diagnosis required positivities of two biomarkers in a single sample or positivities of any biomarker in two consecutive samples. Patients were classified as neither colonized nor infected (n = 48), Candida spp. colonization (n = 154) (low-grade, n = 130; high-grade, n = 24), and IC (n = 31) (intra-abdominal candidiasis, n = 20; candidemia, n = 11). RESULTS: The combination of CAGTA and BDG positivities in a single sample or at least one of the two biomarkers positive in two consecutive samples showed 90.3 % (95 % CI 74.2-98.0) sensitivity, 42.1 % (95 % CI 35.2-98.8) specificity, and 96.6 % (95 % CI 90.5-98.8) negative predictive value. BDG positivities in two consecutive samples had 76.7 % (95 % CI 57.7-90.1) sensitivity and 57.2 % (95 % CI 49.9-64.3) specificity. Mannan-Ag, mannan-Ab, and Candida DNA individually or combined showed a low discriminating capacity. CONCLUSIONS: Positive Candida albicans germ tube antibody and (1 → 3)-ß-D-glucan in a single blood sample or (1 → 3)-ß-D-glucan positivity in two consecutive blood samples allowed discriminating invasive candidiasis from Candida spp. colonization in critically ill patients with severe abdominal conditions. These findings may be helpful to tailor empirical antifungal therapy in this patient population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13054-016-1324-3

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Details of the study methodology
Fig. 1 Details of the study methodologyCC BY · PubMed Central
Fig. 2 Flow-chart of the study population
Fig. 2 Flow-chart of the study populationCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 110

Metadata

Authors
The Cava Trem Study Group, León, C., Ruiz-Santana, S., Saavedra, P., Castro, C., Loza, A., Zakariya, I., Úbeda, A., Parra, M., Macías, D., Tomás, J. I., Rezusta, A., Rodríguez, A., Gómez, F., & Martín-Mazuelos, E.
Affiliations
  • Hospital Universitario de Valme (ES)
  • Universidad de Las Palmas de Gran Canaria (ES)
  • Hospital Universitario Miguel Servet (ES)
  • Hospital Universitari Joan XXIII de Tarragona (ES)
Corresponding author
León, Cristóbal
Venue
Critical Care
Published
2016-05-16
Volume
20
Issue
1
Pages
107-107
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2373438064
Cited by
110
References
39
Citations by year
2026: 6 · 2025: 9 · 2024: 11 · 2023: 8 · 2022: 13 · 2021: 11 · 2020: 12 · 2019: 14 · 2018: 12 · 2017: 11 · 2016: 3
FWCI
12.31
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Critical Care (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • Rovira & Virgili repository (submittedVersion, cc-by)
  • Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
  • Zaguan (Universidad de Zaragoza) (submittedVersion, cc-by)
Funders
  • Instituto de Salud Carlos III (PI 13/01168)
  • Astellas Pharma Europe
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida albicans, β-1,3-glucan, mannan antigen, anti-mannan antibodies, biomarkers, intensive care unit patients, candidemia, intra-abdominal candidiasis, diagnostic accuracy, non-neutropenic patients, systemic antifungal therapy
MeSH terms
Aged, Aged, 80 and over, Antibodies, Fungal, Antifungal Agents, Candida albicans, Female, Humans, Intensive Care Units, Male, Mannans, Middle Aged, Prospective Studies, Biomarkers, Critical Illness, Candidiasis, Invasive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. https://app.cochat.ai/papers/10.1186/s13054-016-1324-3
The paper
The Cava Trem Study Group, León, C., Ruiz-Santana, S., Saavedra, P., Castro, C., Loza, A., Zakariya, I., Úbeda, A., Parra, M., Macías, D., Tomás, J. I., Rezusta, A., Rodríguez, A., Gómez, F., & Martín-Mazuelos, E. (2016). Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions. Critical Care. https://doi.org/10.1186/s13054-016-1324-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.